EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of Phenytoin in Vertigo/Dizziness

Hilal Aydın, Demet Can

Turkish Journal of Pediatric Disease · 2022

DOI: 10.12956/tchd.1002338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Pediatric Disease, 2022. Verfasst von Hilal Aydın und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenytoin is an antiepileptic agent that has been in clinical use for approximately 80 years, particularly due to its antiepileptic and antineuralgic activity and antiarrhythmic effects. Phenytoin has also become increasingly widely used in recent years in various clinical applications, including wound healing, migraine, dizziness, myocardial infarction, bipolar disorder, various types of ulcer, and burns. Vertigo/dizziness is frequently seen in children. Numerous causes play a role in the etiology of vertigo/dizziness. Antiepileptic drugs (particularly carbamazepine and diphenylhydantoin) are also known to give rise to vertigo/dizziness. There are no specific studies concerning the treatment of vertigo/dizziness in childhood, and treatment is reported to involve treatment of the underlying etiology.

Zitieren

APA

Aydın, H., & Can, D. (2022). Use of Phenytoin in Vertigo/Dizziness. Turkish Journal of Pediatric Disease. https://doi.org/10.12956/tchd.1002338

Vancouver

Aydın H, Can D. Use of Phenytoin in Vertigo/Dizziness. Turkish Journal of Pediatric Disease. 2022. doi:10.12956/tchd.1002338

BibTeX
@article{Aydn2022,
  author = {Aydın, Hilal and Can, Demet},
  title = {Use of Phenytoin in Vertigo/Dizziness},
  journal = {Turkish Journal of Pediatric Disease},
  year = {2022},
  doi = {10.12956/tchd.1002338}
}
Kostenlos starten →